Araştırma Makalesi
BibTex RIS Kaynak Göster

Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections

Yıl 2023, Cilt: 13 Sayı: 2, 197 - 205, 25.08.2023

Öz

Aim: Acinetobacter baumannii is an important pathogen causing concern worldwide with increasing antibiotic resistance. We aimed to provide epidemiological data and molecular differences between multidrug resistant A.baumannii isolates obtained from 7 different centers in Türkiye.
Material and Method: One hundred sixty-six multidrug-resistant A.baumannii strains were included in the study. All the isolates were tested for antibiotic susceptibility according to EUCAST criteria. To molecularly confirm the carbapenem-resistant A.baumannii isolates, the specific blaOXA-51-like gene region was detected by polymerase chain reaction (PCR) method. A possible phylogenetic relationship between multi-drug resistant isolates was investigated using Pulsed-field Gel Electrophoresis method.
Results: One hundred sixty-six carbapenem-resistant A.baumannii strains were evaluated by the ApaI-PFGE (Pulsed-field gel electrophoresis –PFGE) method using the CHEF-DRII electrophoresis system. A total of 51 clusters were grouped into 142 pulsotypes. Twenty clusters had single members. Thirty-one clusters had multiple members and were identified with the capital letters of the alphabet such as A, B, …, and Z26. It was observed that 40 PFGE profiles showed 100% related.
Conclusion: More intense contamination is in question in the provinces with many patients. In four of the seven different centers, more innocent results were obtained in terms of the number of samples, antibiotic resistance and clonal relationship when compared to the other three centers. However, this may be caused by the low population zone and inadequate health services. Regional or multicenter studies are minimal. Thus, further studies involving more centers and larger populations are needed. Consequently, the present study will shed light on future studies and create thriving literature on border regions

Kaynakça

  • 1. Davandeh I, Erac B, Aydemir SŞ. Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolates. Turk J Med Sci. 2017;47(5):1661–6.
  • 2. Eroğlu E, Tarakçi A, Çölkesen F, Kacar F, Özdemir Armağan Ş, Can S. Sağlık hizmeti ile ilişkili enfeksiyon etkeni olan Acinetobacter baumannii Suşlarının Değerlendirilmesi. Fırat Tıp Derg. 2022;27(1).
  • 3. Lee CM, Kim CJ, Kim SE, Park KH, Bae JY, Choi HJ, et al. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia. J Glob Antimicrob Resist. 2022;31:45–51.
  • 4. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities; 2017. https://apps.who.int/iris/ handle/10665/259462
  • 5. Sönmez A, Öztürk ŞB, Abacigil F. Sağlık Hizmeti İlişkili Enfeksiyon Epidemiyolojisi ve Sürveyansı. Hemşirelik Bilimi Derg. 2021;4(1):41–5.
  • 6. Kleinpell RM, Munro CL, Giuliano KK. Targeting health careassociated infections: evidence-based strategies. Patient safety and quality: an evidence-based handbook for nurses; 2008.
  • 7. Gülbudak H, Aslan G, Tezcan S, Ersöz G, Ülger M, Otağ F, et al. Hastane enfeksiyonu etkeni olan Acinetobacter baumannii izolatları arasındaki klonal ilişkinin Rep-PCR ile araştırılması. Mikrobiyoloji Bülteni. 2014;48(2):316–24.
  • 8. Boral B, Unaldi Ö, Ergin A, Durmaz R, Eser ÖK. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Ann Clin Microbiol Antimicrob. 2019;18(1):1–9.
  • 9. Biswas I, Rather PN. Acinetobacter baumannii. Springer 2019.
  • 10. Berinson B, Olearo F, Both A, Brossmann N, Christner M, Aepfelbacher M, et al. EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management. J Antimicrob Chemother. 2021;76(5):1332–1338.
  • 11. Gokmen TG, Nagiyev T, Meral M, Onlen C, Heydari F, Koksal F. NDM-1 and rmtC-producing Klebsiella pneumoniae isolates in Turkey. Jundishapur J Microbiol. 2016;9(10).
  • 12. Ibrahimagic A, Kamberovic F, Uzunovic S, Bedenic B, Idrizovic E. Molecular characteristics and antibiotic resistance of Acinetobacter baumannii beta-lactamase-producing isolates, a predominance of intrinsic blaOXA-51, and detection ofTEM and CTX-M genes. Turk J Med Sci. 2017;47(2):715–20.
  • 13. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009;62(5):372–7.
  • 14. Villalón P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez-Nieto JA. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J Clin Microbiol. 2011;49(3):875–82.
  • 15. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res. 2007;126(1):63.
  • 16. Sert S. Türkiye’de sağlık sistemi ve sağlıkta dönüşüm programı(2003–2019). Master’s thesis, Namık Kemal Üniversitesi 2019.
  • 17. Ceylan MR, Karahoca M, Karagöz A, Çikman A, Durmaz R. Çoğul ilaç dirençli Acinetobacter baumannii izolatlarının pulsed-field gel elektroforezis ile klonal ilişkisinin araştırılması. Harran Üniversitesi Tıp Fakültesi Derg. 2020;17(2):297–305.
  • 18. Mete H. Dicle Üniversitesi Tıp fakültesi dahili yoğun bakım ünitelerinde gelişen sağlık hizmeti ile ilişkili enfeksiyonların epidemiyolojisi. Uzmanlık Tezi. Dicle Üniversitesi 2019.
  • 19. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.
  • 20. Gonzalez-Villoria AM, Valverde-Garduno V. Antibioticresistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog. 2016;2016:7318075.
  • 21. Zilberberg MD, Kollef MH, Shorr AF. Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: a survey study. J Hosp Med. 2016;11(1):21–6.
  • 22. Tal-Jasper R, Katz DE, Amrami N, Ravid D, Avivi D, Zaidenstein R, et al. Clinical and epidemiological significance of carbapenem resistance in Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2016;60(5):3127–31.
  • 23. Bayram Y, Gültepe B, Bektaş A, Parlak M, Güdücüoğlu H. Çeşitli klinik örneklerden izole edilen Acinetobacter baumannii suşlarının antibiyotiklere direnç oranlarının araştırılması. Klimik Derg. 2013;26(2):49–53.
  • 24. Rağbetli C, Güdücüoğlu H, Parlak M. Yoğun bakım ünitelerinden izole edilen çok ilaca dirençli Acinetobacter ve Pseudomonas izolatlarında karbapenem direncinin araştırılması. J Contemp Med. 2019;9(3).
  • 25. Gölboyu BE, Dülgeroğlu O, Ekinci M, Karaca Baysal P, Murat K. Yoğun bakım ünitesinde çoklu ilaç dirençli Acinetobacter baumanni enfeksiyonu gelişiminde rol oynayan predispozan faktörler. İzmir Tepecik Eğitim ve Araştırma Hastanesi Derg. 2015;25(3):157–64.
  • 26. Mohammadi Bardbari A, Mohajeri P, Arabestani MR, Karami M, Keramat F, Asadollahi S, et al. Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis. BMC Microbiol. 2020;20(1):1–7.
  • 27. Babaie Z, Delfani S, Rezaei F, Norolahi F, Mahdian S, Shakib P. Molecular detection of carbapenem resistance in acinetobacter baumannii isolated from patients in Khorramabad City, Iran. Infect Disord Drug Targets (Formerly Current Drug TargetsInfectious Disorders) 2020;20(4):543–9.
  • 28. Gumus A, Bozlak CEB. Evaluation of intensive care unit infections in Kafkas University Hospital -a 5 years analysis. Kafkas J Med Sci. 2020;10(3):195–9.
  • 29. Ceylan MR, Karahoca M, Karagöz A, Çikman A, Durmaz R. Çoğul ilaç dirençli Acinetobacter baumannii izolatlarının pulsed-field gel elektroforezis ile klonal ilişkisinin araştırılması. Harran Üniversitesi Tıp Fakültesi Derg. 2020;17(2):297–305.
Yıl 2023, Cilt: 13 Sayı: 2, 197 - 205, 25.08.2023

Öz

Kaynakça

  • 1. Davandeh I, Erac B, Aydemir SŞ. Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolates. Turk J Med Sci. 2017;47(5):1661–6.
  • 2. Eroğlu E, Tarakçi A, Çölkesen F, Kacar F, Özdemir Armağan Ş, Can S. Sağlık hizmeti ile ilişkili enfeksiyon etkeni olan Acinetobacter baumannii Suşlarının Değerlendirilmesi. Fırat Tıp Derg. 2022;27(1).
  • 3. Lee CM, Kim CJ, Kim SE, Park KH, Bae JY, Choi HJ, et al. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia. J Glob Antimicrob Resist. 2022;31:45–51.
  • 4. World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities; 2017. https://apps.who.int/iris/ handle/10665/259462
  • 5. Sönmez A, Öztürk ŞB, Abacigil F. Sağlık Hizmeti İlişkili Enfeksiyon Epidemiyolojisi ve Sürveyansı. Hemşirelik Bilimi Derg. 2021;4(1):41–5.
  • 6. Kleinpell RM, Munro CL, Giuliano KK. Targeting health careassociated infections: evidence-based strategies. Patient safety and quality: an evidence-based handbook for nurses; 2008.
  • 7. Gülbudak H, Aslan G, Tezcan S, Ersöz G, Ülger M, Otağ F, et al. Hastane enfeksiyonu etkeni olan Acinetobacter baumannii izolatları arasındaki klonal ilişkinin Rep-PCR ile araştırılması. Mikrobiyoloji Bülteni. 2014;48(2):316–24.
  • 8. Boral B, Unaldi Ö, Ergin A, Durmaz R, Eser ÖK. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Ann Clin Microbiol Antimicrob. 2019;18(1):1–9.
  • 9. Biswas I, Rather PN. Acinetobacter baumannii. Springer 2019.
  • 10. Berinson B, Olearo F, Both A, Brossmann N, Christner M, Aepfelbacher M, et al. EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management. J Antimicrob Chemother. 2021;76(5):1332–1338.
  • 11. Gokmen TG, Nagiyev T, Meral M, Onlen C, Heydari F, Koksal F. NDM-1 and rmtC-producing Klebsiella pneumoniae isolates in Turkey. Jundishapur J Microbiol. 2016;9(10).
  • 12. Ibrahimagic A, Kamberovic F, Uzunovic S, Bedenic B, Idrizovic E. Molecular characteristics and antibiotic resistance of Acinetobacter baumannii beta-lactamase-producing isolates, a predominance of intrinsic blaOXA-51, and detection ofTEM and CTX-M genes. Turk J Med Sci. 2017;47(2):715–20.
  • 13. Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009;62(5):372–7.
  • 14. Villalón P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez-Nieto JA. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J Clin Microbiol. 2011;49(3):875–82.
  • 15. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res. 2007;126(1):63.
  • 16. Sert S. Türkiye’de sağlık sistemi ve sağlıkta dönüşüm programı(2003–2019). Master’s thesis, Namık Kemal Üniversitesi 2019.
  • 17. Ceylan MR, Karahoca M, Karagöz A, Çikman A, Durmaz R. Çoğul ilaç dirençli Acinetobacter baumannii izolatlarının pulsed-field gel elektroforezis ile klonal ilişkisinin araştırılması. Harran Üniversitesi Tıp Fakültesi Derg. 2020;17(2):297–305.
  • 18. Mete H. Dicle Üniversitesi Tıp fakültesi dahili yoğun bakım ünitelerinde gelişen sağlık hizmeti ile ilişkili enfeksiyonların epidemiyolojisi. Uzmanlık Tezi. Dicle Üniversitesi 2019.
  • 19. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–82.
  • 20. Gonzalez-Villoria AM, Valverde-Garduno V. Antibioticresistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog. 2016;2016:7318075.
  • 21. Zilberberg MD, Kollef MH, Shorr AF. Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: a survey study. J Hosp Med. 2016;11(1):21–6.
  • 22. Tal-Jasper R, Katz DE, Amrami N, Ravid D, Avivi D, Zaidenstein R, et al. Clinical and epidemiological significance of carbapenem resistance in Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2016;60(5):3127–31.
  • 23. Bayram Y, Gültepe B, Bektaş A, Parlak M, Güdücüoğlu H. Çeşitli klinik örneklerden izole edilen Acinetobacter baumannii suşlarının antibiyotiklere direnç oranlarının araştırılması. Klimik Derg. 2013;26(2):49–53.
  • 24. Rağbetli C, Güdücüoğlu H, Parlak M. Yoğun bakım ünitelerinden izole edilen çok ilaca dirençli Acinetobacter ve Pseudomonas izolatlarında karbapenem direncinin araştırılması. J Contemp Med. 2019;9(3).
  • 25. Gölboyu BE, Dülgeroğlu O, Ekinci M, Karaca Baysal P, Murat K. Yoğun bakım ünitesinde çoklu ilaç dirençli Acinetobacter baumanni enfeksiyonu gelişiminde rol oynayan predispozan faktörler. İzmir Tepecik Eğitim ve Araştırma Hastanesi Derg. 2015;25(3):157–64.
  • 26. Mohammadi Bardbari A, Mohajeri P, Arabestani MR, Karami M, Keramat F, Asadollahi S, et al. Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis. BMC Microbiol. 2020;20(1):1–7.
  • 27. Babaie Z, Delfani S, Rezaei F, Norolahi F, Mahdian S, Shakib P. Molecular detection of carbapenem resistance in acinetobacter baumannii isolated from patients in Khorramabad City, Iran. Infect Disord Drug Targets (Formerly Current Drug TargetsInfectious Disorders) 2020;20(4):543–9.
  • 28. Gumus A, Bozlak CEB. Evaluation of intensive care unit infections in Kafkas University Hospital -a 5 years analysis. Kafkas J Med Sci. 2020;10(3):195–9.
  • 29. Ceylan MR, Karahoca M, Karagöz A, Çikman A, Durmaz R. Çoğul ilaç dirençli Acinetobacter baumannii izolatlarının pulsed-field gel elektroforezis ile klonal ilişkisinin araştırılması. Harran Üniversitesi Tıp Fakültesi Derg. 2020;17(2):297–305.
Toplam 29 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Mikrobiyoloji
Bölüm Araştırma Makalesi
Yazarlar

Ayşe Karacalı Tunç Bu kişi benim

Togrul Nagiyev Bu kişi benim

Tülay Kandemir Bu kişi benim

Melda Meral Öcal Bu kişi benim

Fatih Köksal Bu kişi benim

Erken Görünüm Tarihi 15 Eylül 2023
Yayımlanma Tarihi 25 Ağustos 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 13 Sayı: 2

Kaynak Göster

APA Karacalı Tunç, A., Nagiyev, T., Kandemir, T., Öcal, M. M., vd. (2023). Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections. Kafkas Journal of Medical Sciences, 13(2), 197-205.
AMA Karacalı Tunç A, Nagiyev T, Kandemir T, Öcal MM, Köksal F. Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections. Kafkas Journal of Medical Sciences. Ağustos 2023;13(2):197-205.
Chicago Karacalı Tunç, Ayşe, Togrul Nagiyev, Tülay Kandemir, Melda Meral Öcal, ve Fatih Köksal. “Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Infections”. Kafkas Journal of Medical Sciences 13, sy. 2 (Ağustos 2023): 197-205.
EndNote Karacalı Tunç A, Nagiyev T, Kandemir T, Öcal MM, Köksal F (01 Ağustos 2023) Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections. Kafkas Journal of Medical Sciences 13 2 197–205.
IEEE A. Karacalı Tunç, T. Nagiyev, T. Kandemir, M. M. Öcal, ve F. Köksal, “Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections”, Kafkas Journal of Medical Sciences, c. 13, sy. 2, ss. 197–205, 2023.
ISNAD Karacalı Tunç, Ayşe vd. “Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Infections”. Kafkas Journal of Medical Sciences 13/2 (Ağustos 2023), 197-205.
JAMA Karacalı Tunç A, Nagiyev T, Kandemir T, Öcal MM, Köksal F. Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections. Kafkas Journal of Medical Sciences. 2023;13:197–205.
MLA Karacalı Tunç, Ayşe vd. “Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Infections”. Kafkas Journal of Medical Sciences, c. 13, sy. 2, 2023, ss. 197-05.
Vancouver Karacalı Tunç A, Nagiyev T, Kandemir T, Öcal MM, Köksal F. Multicenter Research of the Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Infections. Kafkas Journal of Medical Sciences. 2023;13(2):197-205.